PL2892556T3 - Kompozycje i sposoby odnoszące się do leczenia chorób - Google Patents

Kompozycje i sposoby odnoszące się do leczenia chorób

Info

Publication number
PL2892556T3
PL2892556T3 PL13763273T PL13763273T PL2892556T3 PL 2892556 T3 PL2892556 T3 PL 2892556T3 PL 13763273 T PL13763273 T PL 13763273T PL 13763273 T PL13763273 T PL 13763273T PL 2892556 T3 PL2892556 T3 PL 2892556T3
Authority
PL
Poland
Prior art keywords
diseases
compositions
treatment
methods relating
relating
Prior art date
Application number
PL13763273T
Other languages
English (en)
Inventor
William Stimson
Original Assignee
Alfacyte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfacyte Ltd filed Critical Alfacyte Ltd
Publication of PL2892556T3 publication Critical patent/PL2892556T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL13763273T 2012-09-05 2013-09-04 Kompozycje i sposoby odnoszące się do leczenia chorób PL2892556T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1215873.9A GB201215873D0 (en) 2012-09-05 2012-09-05 Compositions and methods relating to the treatment of allergy and allergic diseases
PCT/GB2013/052316 WO2014037717A1 (en) 2012-09-05 2013-09-04 Compositions and methods relating to the treatment of diseases
EP13763273.3A EP2892556B1 (en) 2012-09-05 2013-09-04 Compositions and methods relating to the treatment of diseases

Publications (1)

Publication Number Publication Date
PL2892556T3 true PL2892556T3 (pl) 2019-11-29

Family

ID=47136996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13763273T PL2892556T3 (pl) 2012-09-05 2013-09-04 Kompozycje i sposoby odnoszące się do leczenia chorób

Country Status (8)

Country Link
US (1) US9522173B2 (pl)
EP (1) EP2892556B1 (pl)
CA (1) CA2884092C (pl)
DK (1) DK2892556T3 (pl)
ES (1) ES2734550T3 (pl)
GB (1) GB201215873D0 (pl)
PL (1) PL2892556T3 (pl)
WO (1) WO2014037717A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201404403D0 (en) * 2014-03-12 2014-04-23 Alfacyte Ltd Compositions and methods relating to the treatment of diseases
HUE065662T2 (hu) * 2015-09-15 2024-06-28 Ilc Therapeutics Ltd Készítmények és eljárások betegségek kezelésére
JP7406254B2 (ja) 2018-06-01 2023-12-27 アイエルシー セラピューティクス リミテッド 疾患の治療に関する組成物および方法
GB202003595D0 (en) 2020-03-12 2020-04-29 Ilc Therapeutics Ltd Compositions and methods relating to the treatment of diseases
CA3170629A1 (en) 2020-03-16 2021-09-23 William Stimson Hybrid interferons for treating viral infections
GB202003812D0 (en) 2020-03-16 2020-04-29 Ilc Therapeutics Ltd Compositions and methods relating to the treatment of diseases
GB202010314D0 (en) 2020-07-06 2020-08-19 Ilc Therapeutics Ltd Cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT741577E (pt) 1994-03-07 2003-03-31 Imperial College Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
US6436391B1 (en) * 1997-01-31 2002-08-20 Imperial College Of Science, Technology & Medicine Use of interferon (IFN)-α8 and -α14 as vaccine adjuvants
US6350589B1 (en) 1998-12-31 2002-02-26 Viragen, Inc. Compositions of highly-purified natural mixtures of type I interferon derived from leukocytes and methods
FR2825102B1 (fr) * 2001-05-23 2003-08-29 Genodyssee Nouveaux polynucleotides et polypeptides de l'interferon alpha 14
JP2008502732A (ja) * 2004-06-12 2008-01-31 ファーマ パシフィック プロプリエタリイ リミテッド ワクチンに対する免疫応答を増強する方法
WO2006111745A2 (en) * 2005-04-20 2006-10-26 Viragen Incorporated Composition and method for treating viral infection

Also Published As

Publication number Publication date
US9522173B2 (en) 2016-12-20
ES2734550T3 (es) 2019-12-10
EP2892556B1 (en) 2019-05-15
WO2014037717A1 (en) 2014-03-13
US20150209410A1 (en) 2015-07-30
CA2884092C (en) 2023-07-25
GB201215873D0 (en) 2012-10-24
CA2884092A1 (en) 2014-03-13
DK2892556T3 (da) 2019-08-05
EP2892556A1 (en) 2015-07-15

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
EP2925775A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLISM DISEASES AND DRESSINGS
EP2831001A4 (en) COMPOSITION FOR THE TREATMENT OF WATER AND METHOD FOR USE
PL2925757T3 (pl) Związki i kompozycje do leczenia chorób pasożytniczych
EP2621499A4 (en) METHODS OF TREATING ALLERGIC DISEASES
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
IL233674A0 (en) Preparations and methods for using phorbol esters for stroke treatment
DK3292875T3 (en) Compositions and methods for treating diseases
IL230770A0 (en) Methods and preparations related to p-62 for the treatment and prevention of cancer
IL238177A0 (en) Methods and preparations for the treatment of cancer
IL233639A0 (en) Preparations and methods for the treatment of diseases and liver disorders
ZA201408055B (en) Compositions and methods for the treatment of local pain
ZA201408056B (en) Compositions and methods for the treatment of mucositis
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
ZA201503979B (en) Treatment of diseases involving mucin
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
EP2709632A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
SG10201706453XA (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
EP2934501A4 (en) USES AND METHOD FOR THE TREATMENT OF LIVER DISEASES OR DRESSES
SG11201504779YA (en) Methods and compositions relating to treatment of cancer
ZA201408065B (en) Compositions and methods for the treatment of diabetes
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
IL231490A0 (en) Preparations and methods for the production and use of human cholinesterases